Addressing protein aggregation, product stability, supply chains, and regulations requires multiple tools, including ...

Typically, GMMAs have to be engineered so they can be produced in sufficient quantities for vaccination, as well as to strip out any potentially harmful components, like endotoxins. NgG is now in ...